HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Jia Selected Research

nootkatone

4/2021Nootkatone improves anxiety- and depression-like behavior by targeting hyperammonemia-induced oxidative stress in D-galactosamine model of liver injury.
3/2020Synergistic neuroprotective effect of schisandrin and nootkatone on regulating inflammation, apoptosis and autophagy via the PI3K/AKT pathway.
12/2019Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer's disease mice model.
9/2018Nootkatone, a neuroprotective agent from Alpiniae Oxyphyllae Fructus, improves cognitive impairment in lipopolysaccharide-induced mouse model of Alzheimer's disease.
1/2018Neuroprotective effects of nootkatone from Alpiniae oxyphyllae Fructus against amyloid-β-induced cognitive impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Jia Research Topics

Disease

16Cognitive Dysfunction
03/2022 - 01/2014
15Alzheimer Disease (Alzheimer's Disease)
01/2021 - 12/2014
12Neoplasms (Cancer)
01/2022 - 01/2011
10Inflammation (Inflammations)
07/2022 - 09/2019
8Sleep Initiation and Maintenance Disorders (Insomnia)
06/2020 - 10/2012
6Neuroinflammatory Diseases
03/2022 - 09/2018
5Dementia (Dementias)
06/2020 - 09/2014
4Diarrhea
05/2020 - 09/2012
4Memory Disorders (Memory Loss)
01/2019 - 01/2014
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 02/2013
3Infections
01/2022 - 05/2006
3Lung Neoplasms (Lung Cancer)
01/2022 - 07/2014
3Body Weight (Weight, Body)
11/2021 - 05/2019
3Type 2 Diabetes Mellitus (MODY)
11/2021 - 05/2019
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2021 - 07/2011
3Cerebral Hemorrhage
11/2020 - 08/2010
2Carcinogenesis
01/2022 - 01/2022
2Adenocarcinoma of Lung
01/2022 - 03/2021
2Parkinson Disease (Parkinson's Disease)
05/2021 - 12/2019
2Hyperammonemia
04/2021 - 04/2021
2Heart Failure
04/2021 - 05/2019
2Reperfusion Injury
03/2021 - 01/2021
2Brain Ischemia (Cerebral Ischemia)
03/2021 - 12/2011
2Obesity
01/2021 - 01/2020
2Insulin Resistance
11/2020 - 08/2018
2Cystic Fibrosis (Mucoviscidosis)
01/2020 - 01/2018
2Breast Neoplasms (Breast Cancer)
04/2019 - 01/2012
2Diabetes Mellitus
08/2018 - 07/2014
2Toothache (Toothaches)
11/2016 - 05/2016
2Stroke (Strokes)
03/2013 - 07/2011
1Glioblastoma (Glioblastoma Multiforme)
10/2022
1Dyspepsia (Indigestion)
07/2022
1Hypoglycemia (Reactive Hypoglycemia)
02/2022
1Fever (Fevers)
01/2022
1Human Influenza (Influenza)
01/2022
1Cough
01/2022
1Squamous Intraepithelial Lesions
01/2022
1Brain Injuries (Brain Injury)
11/2021

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2006
7Neuroprotective AgentsIBA
06/2020 - 09/2014
6Polysaccharides (Glycans)IBA
06/2020 - 05/2019
5nootkatoneIBA
04/2021 - 01/2018
4Phosphotransferases (Kinase)IBA
10/2022 - 07/2011
4LipopolysaccharidesIBA
03/2022 - 05/2018
4Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2020
4Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2021 - 04/2019
4schizandrinIBA
04/2021 - 12/2014
3Pharmaceutical PreparationsIBA
07/2022 - 03/2013
3NicotineFDA Link
01/2022 - 07/2014
3Streptozocin (Streptozotocin)FDA Link
11/2021 - 07/2014
3LignansIBA
01/2021 - 01/2016
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 12/2011
3Amyloid (Amyloid Fibrils)IBA
05/2020 - 01/2014
3Hypnotics and Sedatives (Sedatives)IBA
01/2015 - 07/2014
3PolyaminesIBA
02/2013 - 01/2011
2Glucagon-Like Peptide 1 (GLP 1)IBA
07/2022 - 11/2020
2Silybin (Lagosa)IBA
02/2022 - 08/2018
2Estrogen ReceptorsIBA
02/2022 - 01/2012
2Cholinergic ReceptorsIBA
01/2022 - 01/2022
2Blood Glucose (Blood Sugar)IBA
11/2021 - 05/2019
2AntioxidantsIBA
04/2021 - 05/2019
2FlavonoidsIBA
01/2021 - 01/2019
2Caspase 3 (Caspase-3)IBA
11/2020 - 08/2017
2NucleotidesIBA
08/2020 - 10/2018
2suanzaorenIBA
06/2020 - 10/2012
2spinosinIBA
05/2020 - 01/2019
2Interleukin-6 (Interleukin 6)IBA
03/2020 - 09/2019
2Antidepressive Agents (Antidepressants)IBA
02/2020 - 12/2019
2Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2020 - 01/2018
2schisantherin BIBA
03/2019 - 12/2016
2tectochrysinIBA
01/2019 - 07/2018
2Ethanol (Ethyl Alcohol)IBA
07/2018 - 12/2014
2Scopolamine (Hyoscine)FDA Link
01/2018 - 12/2016
2Therapeutic UsesIBA
11/2016 - 02/2008
2gamma-Aminobutyric Acid (GABA)IBA
12/2014 - 01/2014
25-Hydroxytryptophan (5 Hydroxytryptophan)IBA
12/2014 - 07/2014
2Flumazenil (Romazicon)FDA LinkGeneric
12/2014 - 07/2014
2Fenclonine (p-Chlorophenylalanine)IBA
12/2014 - 07/2014
2Caffeine (No Doz)FDA LinkGeneric
12/2014 - 07/2014
1tyrosine receptor (receptor, tyrosine)IBA
10/2022
1AntralIBA
07/2022
1Cisplatin (Platino)FDA LinkGeneric
07/2022
1milk-thistle extractIBA
02/2022
1SilymarinIBA
02/2022
1Oseltamivir (Tamiflu)FDA Link
01/2022
1InflammasomesIBA
01/2022
1HMGB1 Protein (HMG1)IBA
11/2021
1LiraglutideFDA Link
11/2021
1Oxygen (Dioxygen)IBA
10/2021
1Glucose (Dextrose)FDA LinkGeneric
10/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2021
1Superoxide DismutaseIBA
04/2021
1Malondialdehyde (Propanedial)IBA
04/2021
1Glutathione (Reduced Glutathione)IBA
04/2021

Therapy/Procedure

5Therapeutics
01/2022 - 01/2021
5Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2020 - 10/2012
2Aftercare (After-Treatment)
01/2021 - 02/2008
2Acupuncture Points (Acupuncture Point)
11/2016 - 05/2016
1Ambulatory Care (Outpatient Care)
01/2022
1Curettage
01/2022